search 2013 adfgs

Press Releases

BioNJ Human Resource Conference on Culture Connection Taking Place on May 9

TRENTON, NJ (April 22) – Working from the theme The Culture Connection: Transforming and Creating Cultures that Thrive!, BioNJ, the trade association for New Jersey’s life science industry, will host its 3rd Annual Human Resource Industry Conference on May 9, 2014 from 8:00 a.m. to 5:00 p.m. at the Bridgewater Marriott in Bridgewater, NJ.

The Conference will bring together a variety of business leaders and recognized experts, all of whom bring a wealth of practical knowledge and experience.  Industry human resources professionals will benefit from this unique opportunity to network broadly, while at the same time gaining exposure to innovative initiatives happening now inside local New Jersey companies.

This year’s dynamic Keynote Speaker is Christine Roess, Founding Partner of SDI Communications.  She will provide insight from her work conducting transformational leadership training and executive coaching, as well as from her own fascinating life experiences in a presentation entitled, From Culture Consumer to Culture Creator: A 21st Century Paradigm.  The presentation will address the need for leadership and collaboration as organization hierarchies morph into flattened networks of living, breathing human beings who want to make a difference.

Four expert panels will share their perspectives on current trends and topics, which will include: On Our Radar – Legal Trends and Hot Topics, Impressive Beginnings – Innovative Practices in Onboarding and Branding; Getting it Right:  The Culture Equation – Views and Perspectives from across the Organization, and, The Culture Impact:  How Companies Are Influencing Culture through Performance Management Systems.

In addition, conference attendees will hear first-hand from experts and leaders from a wide variety of employers including Actavis, Celgene Corporation, Cornerstone Search Group , Covance, Drinker Biddle & Reath, Ferring Pharmaceuticals, Google, Ikaria, Insmed Incorporated, JBK Associates, Janssen Pharmaceuticals, Johnson & Johnson, Korn Ferry, Novartis, PTC Therapeutics and Reed Smith.

The Lead Sponsor for BioNJ’s HR Conference will be Cornerstone Search Group, whose client services include providing companies with customized & performance-based Executive Retained Search as effective and efficient alternatives to traditional Retained Search services.  Additional sponsors include, Joulé Clinical & Scientific Staffing Solutions, Scient Federal Credit Union and Scientific Search.  BioNJ’s HR Industry Conference provides a powerful opportunity for Human Resources leaders and their staffs to remain contemporary and to experience how other employers are cultivating initiatives to engage and inspire talent.

A limited number of discounted tickets are available for industry HR professionals who may be in-transition.  Please contact BioNJ for more information: SShaw@BioNJ.org

About BioNJ

With more than 300 member companies, BioNJ is focused on the growth and prosperity of New Jersey’s life sciences cluster. Founded in 1994 by New Jersey industry CEOs, BioNJ serves as the voice of companies located in New Jersey, seeks to advance their economic growth and development and works to encourage new and established companies from around the world to locate in New Jersey. BioNJ represents companies engaged in biopharmaceutical, biomedical, bioagricultural and bioremedial endeavors.

 

MEDIA CONTACTS:

Bill O’Donnell
BioNJ
(609) 890-3185, Ext. 117
(609) 802-3091
Bodonnell@bionj.org

Second Annual BioNJ Diagnostics & Personalized Medicine Innovation Summit Taking Place at Sanofi

 Life Science Industry Leaders and Innovator Companies Meet to Network and Identify Partnership Opportunities that Advance Personalized Medicine

TRENTON, NJ (May 8th, 2013)— BioNJ, the trade association for New Jersey’s biotechnology industry, is hosting its biggest and most interactive event of the year for companies involved in diagnostics and personalized medicine on June 6, 2013 at Sanofi’s US headquarters in Bridgewater, NJ.

Expanded this year due to the success of last year’s inaugural event, the 2013 BioNJ Diagnostics & Personalized Medicine Innovation Summit will bring together leaders from major global biotechnology and pharmaceutical companies, diagnostics companies and emerging “innovator” companies for a full-day, interactive summit meeting.

We were delighted with the level of interest and participation in last year’s event,” said Debbie Hart, President of BioNJ. “So this year we are doing it bigger and better, extending the agenda to a full day and bringing in more first-class speakers from all key constituencies involved with diagnostics and personalized medicine. The BioNJ Diagnostics & Personalized Medicine Innovation Summit has quickly become a ‘must-attend’ event for anybody interested in this exciting new frontier of medicine, where a lot of New Jersey companies are leading the way.

Part of BioNJ’s ongoing Diagnostics & Personalized Medicine Initiative, the focus of this summit is to help participants identify opportunities for partnership, funding and growth while updating them on the latest trends, developments and challenges in the evolution and adoption of personalized medicine. All companies and individuals with an interest in diagnostics and personalized medicine are welcome to attend this event. The Summit will include company presentations and opportunities for one-on-one communication and interaction between leading global pharmaceutical and biotechnology companies, emerging diagnostics companies, funding organizations and life sciences company business development professionals.

Keynote speakers at the 2013 Summit include leaders from global life sciences companies as well as the investment community:

G. Steven Burrill
Chief Executive Officer, Burrill & Company

Elias Zerhouni, MD
President, Global R&D, Sanofi

In addition to keynote speakers, the agenda includes a series of moderated interactive panel discussions focused on research and commercialization challenges in diagnostics and personalized medicine.

Sanofi is fully committed to researching, developing and introducing new products and technologies that deliver on the promise of personalized medicine, and we are excited to be part of this BioNJ event,” said Marc Bonnefoi, DVM, Ph.D., Head of the North America R&D Hub and Vice President of Disposition, Safety and Animal Research Scientific Core Platform at Sanofi, and a Board Member of BioNJ. “Better patient outcomes through more precise diagnostics, targeted therapies, increased efficiencies in healthcare delivery, and lower healthcare costs are just a few examples of how personalized medicine could transform healthcare, and our organization is working hard worldwide to contribute to this transformation.

The BioNJ Diagnostics and Personalized Medicine Committee, which has created the BioNJ Diagnostics & Personalized Medicine Innovation Summit, is also planning additional events focusing on diagnostics and personalized medicine, and will be announcing details for future events on its web site, www.BioNJ.org.

About the BioNJ Diagnostics Committee

The BioNJ Diagnostics and Personalized Medicine Committee was created to advance personalized medicine through diagnostics by identifying and supporting partnerships with industry, academic, government and investors in the State of New Jersey.

The goal of the committee is to define and accelerate new areas of diagnostics, such as in vivo and in vitro tests, biomarkers, imaging, information systems and other innovative technologies.

About BioNJ

With more than 300 member companies, BioNJ is singularly focused on the growth and prosperity of New Jersey’s biotechnology cluster.  Founded in 1994 by New Jersey industry CEOs, BioNJ serves as the voice of biotechnology companies located in New Jersey, seeks to advance their economic growth and development and works to encourage new and established companies from around the world to locate in New Jersey. BioNJ represents companies engaged in biopharmaceutical, biomedical, bioagricultural and bioremedial endeavors.

BioNJ To Host 2nd Annual Life Sciences Industry HR Conference On May 20

TRENTON, NJ (April 30, 2013)Due to the popularity and success of its 2012 event, BioNJ is pleased to announce it will host the 2nd Annual Human Resource Conference on Monday, May 20, 2013, from 8:00 a.m. to 5:00 p.m. at the Hilton East Brunswick Hotel, East Brunswick, NJ.  This year’s theme will focus on the concept of Transition & Transformation:  Proactive Strategies for Life Sciences.

A dynamic opening panel of senior leaders will share perspectives on the topic of Leadership During Times of Transition and Transformation to kick off the agenda.  The panel will be moderated by Chris Martin, Senior Vice President, Enterprise Solutions for Randstad Professionals and will include Karen A. DiSanto, Associate Vice President, Human Resources of Ferring Pharmaceuticals; Bill Mann, CEO of Helsinn Therapeutics, Inc.; Francois Nader, M.D., President and CEO of NPS Pharmaceuticals, Inc.; and Joan Winterbottom, Senior Vice President, Human Resources of Amicus Therapeutics, Inc.

This powerful panel will discuss leadership during times of transition and transformation and will focus on the impact that human resources can have on an organization’s journey through significant change.

Read more »

NORD, BioNJ and Patient Advocacy Groups to Collaborate on Rare Disease Day Event at New Jersey State House

TRENTON, NJ (February 13, 2013) — The National Organization for Rare Disorders, BioNJ and 11 New Jersey-based patient advocacy groups are joining forces for a unique educational event about rare diseases to be held at the New Jersey State House on March 4, 2013. The gathering, which will convene local leaders from government, non-profit, and the biotechnology sector, will be conducted on behalf of state residents living with rare diseases that plague nearly 1 in every 10 Americans. The event is highlighted by a New Jersey success story – the latest in-state biopharmaceutical company to offer a significant treatment advance for one group of patients with a rare intestinal disorder.

Patients, researchers, health care advocates, members of the New Jersey government and biotech industry, as well as concerned citizens are invited to attend the event on Monday, March 4, 2013, from 11:30 a.m. to 12:30 p.m. at Committee Room 11, 4th floor, Annex Building, New Jersey Statehouse.

Read more »

BioNJ Installs New Chair, Members on its Board of Trustees

EAST BRUNSWICK, NJ (February 13, 2013)– BioNJ, the voice of more than 350 biotech companies located in New Jersey, installed a new chairman and several new board members at its 20th Annual Meeting here last week.

The Board took the action at BioNJ’s 2013 Annual Meeting, Awards Program and Networking Event at the Hilton East Brunswick on Thursday, February 7, where some 700 industry leaders and associates turned out to celebrate the organization and the industry with a dinner, roundtable discussion and awards presentations.

New Jersey Lt. Governor Kim Guadagno served as the keynote speaker for the event.  She praised the life sciences industry’s economic and social contributions to the state’s well-being and pledged the continued support of the administration of Governor Chris Christie.

Read more »

NJ Biotechnology Industry Continues to Grow; Number of Companies and Employees Increasing

BioNJ/E&Y Survey Sees 13 Percent Plus Increase in Companies
9.3 Percent Increase in Employees over 2010 Data

 Early-Stage Funding a Continuing Issue

TRENTON, NJ (August 6, 2012) ─ The biotechnology industry in New Jersey continues to demonstrate vitality, experiencing important increases in both the number of companies operating in the State and the number of employees working for those companies, according to the results of a survey conducted by Ernst & Young on behalf of BioNJ.  The survey also confirmed data derived from previous BioNJ surveys which indicate that access to funding remains the primary challenge impacting the growth of early-stage companies.

The number of biotechnology companies with operations in New Jersey increased from more than 300 in a previous BioNJ study in July 2010 to more than 340 today, representing an increase of more than 13 percent, according to the study, Biotech in New Jersey: Finding Its Way Through Continuing Challenges.

The number of employees working directly at those New Jersey biotechnology companies also increased, rising 9.3 percent in the last two years, from approximately 15,000 employees in July 2010 to an estimated 16,400 in 2012. Read more »

NJ Governor Chris Christie Recognized as BIO 2012 Governor of the Year

We are pleased to report that New Jersey Governor Chris Christie was honored as the BIO 2012 Governor of the Year. The BIO Governor of the Year Award honors a governor who has demonstrated outstanding leadership in support of the biotechnology industry.

Please see below of a video in which Governor Christie made his acceptance speech following a presentation of the award by BIO Board Member and Celgene Executive Vice President and Chief Operations Officer Perry A. Karsen and BioNJ President Debbie Hart. Read more »

BioNJ Joins Effort to Bring Life Science Education, Workforce Training and Entrepreneurship to the National Stage

BOSTON (June 20, 2012)-BioNJ, the trade association for New Jersey’s thriving biotechnology industry, has joined 40 other state bioscience organizations in a nationally coordinated effort to ensure that the United States will continue its global leadership in bioscience innovation by developing and delivering industry-led life science education, workforce development and entrepreneurship programs across the county.

BioNJ has signed on to be a member of this newly established group – the Coalition of Bioscience Institutes (CSBI). The formation of CSBI was announced at the 2012 BIO International Convention, the industry’s global event for biotechnology that is hosted by the Biotechnology Industry Organization (BIO). Read more »

NJ Lt. Governor and BioNJ Honor NJ Student for Top Honors at International Biology Olympiad during BIO International Convention

BioNJ President Debbie Hart, left, and Lt. Governor Kim Guadagno, right, congratulate Rebecca Shi, for her outstanding achievements at the 2011 International Biology Olympiad.

BOSTON - (June 20, 2012) A New Jersey teen who as a high school senior earned top honors at the 2011 International Biology Olympiad was honored yesterday by New Jersey Lt. Governor Kim Guadagno and BioNJ President Debbie Hart at a special ceremony here during the world’s largest annual biotechnology conference. Read more »

BioNJ Life Sciences Talent Network to Host “Career Connection” Job Fair & BioHUB Networking Event for Life Science Industry Professionals

TRENTON, N.J.–The BioNJ Life Sciences Talent Network (LSTN) will host a life sciences job fair, “CareerConnection,” on Tuesday, June 26, 2012, from 9:00 a.m. to 3:00 p.m. at the Rutgers University Student Center located at 126 College Avenue, New Brunswick, NJ.

The CareerConnection job fair is intended for professionals and job seekers within the life science industry and will offer attendees opportunities to meet with employers, industry recruiters/headhunters, education providers and career counselors, as well as connect with other professional organizations. Read more »

BioNJ Presents Fifth Annual Dr. Sol J. Barer Award for Vision, Innovation, and Leadership to Paul G. Thomas of Roka Bioscience

TRENTON, N.J.–(December 15)–BioNJ, New Jersey’s trade association for the biotechnology community, announced today that the fifth annual Dr. Sol J. Barer Award for Vision, Innovation, and Leadership has been awarded to Paul G. Thomas, Founder and CEO of Roka Bioscience. Named for Sol J. Barer, Ph.D., a Senior Advisor and former Chairman and CEO of Celgene Corporation of Summit, N.J., the award recognizes outstanding research and business leaders who have made significant contributions to the growth and prosperity of the biosciences industry in New Jersey and throughout the world. Read more »

New Jersey Governor Chris Christie to Address BioNJ 2012 Annual Meeting

TRENTON, NJ (November 16) – BioNJ, the trade association for New Jersey’s growing biotechnology industry, will welcome New Jersey Governor Chris Christie to address attendees at the association’s 2012 Annual Dinner Meeting, Awards Program and Networking Event on Thursday, February 2.  The event will be held at the East Brunswick Hilton in East Brunswick, NJ beginning at 5:00 p.m. Read more »

Oncobiologics Ribbon Cutting Ceremony – October 14, 2011

Senator Menendez, Lt. Governor Guadagno Unveil New Biotech Firm Oncobiologics

Announcing Joint Ventures, Cranbury Company Will Generate 200 NJ Jobs

Cranbury, NJ, October 14, 2011 – Senator Robert Menendez (D-NJ), Lt. Governor Kim Guadagno and regional leaders of the biopharmaceutical industry today unveiled the state-of-the-art home of Oncobiologics, a novel biotech firm enabled, in part, by the U.S. Affordable Care Act.

Read more »

High Profile Delegation of Life Sciences CEOs from Bordeaux Visits America’s Medicine Chest State

TRENTON, N.J.–(BUSINESS WIRE)–Chief Executive Officers (CEOs) representing eight flagship biotechnology and life science companies from Bordeaux, France, will visit New Jersey June 15-16 to engage in bilateral trade discussions with biotechnology and other life science companies located in the Garden State.

The delegation is supported by the Chamber of Commerce and Industry of Bordeaux, the Regional Council of Aquitaine, where Bordeaux is the capital, and GIPSO (le Groupement Interprofessionel de Pharmaceutiques et Sante du Sud Oest) and hosted by BioNJ, Choose New Jersey, the New Jersey Business Action Center and Princeton University. Read more »

BioNJ and Publicis Healthcare Communications Group Partner On Forum to Explore Complex Biosimilar Issues

New York, NY, June 6, 2011—As billions of biotech products are set to go off patent, Congress and industry look to biosimilar legislation to guide next steps.  Publicis Healthcare Communications Group (PHCG) and BioNJ convened a panel of top industry experts to discuss “Biosimilars and Protecting R&D Dollars” on June 2, 2011 in Bridgewater, New Jersey. Read more »

BioNJ Webinar Focuses on the Future of Personalized Medicine

Industry Leaders Highlight the Role of Diagnostics in Enhancing the Value and Improving Outcomes for Therapeutics, Making Personalized Medicine a Reality

TRENTON, NJ (May 5, 2010)—The growing interrelationship between diagnostics and therapeutics to deliver improvements in patient outcomes, reduce overall healthcare costs and increase the productivity of drug discovery was addressed by leaders in diagnostics and personalized medicine in a webinar hosted at BioNJ, the voice of the biotechnology industry in New Jersey. Read more »

New Jersey among Top States under Qualifying Therapeutic Discovery Project


TRENTON, NJ (Nov. 3, 2010) – BioNJ President Debbie Hart issued the following statement today following the announcement by U.S. Treasury Secretary Timothy Geithner and Health and Human Services Secretary Kathleen Sebelius of the recipients of the $1 billion Therapeutic Discovery Project: Read more »

Employment at NJ Biotechnology Companies Growing

Employment at NJ Biotechnology Companies Growing
Industry Survey Sees 50 Percent Growth from 2007 to 2010
Access to Capital Remains Constrained

TRENTON, NJ (July 29, 2010) ─ The number of employees working at New Jersey biotechnology companies increased by 50 percent in the last three years, growing from 10,000 employees in 2007 to an estimated 15,000 in 2010, Read more »

New Jersey Biotechnology Continues to See Growth

Number of NJ Companies Continues to Increase in Latest Survey
Early-Stage Funding a Continuing Issue

TRENTON, NJ (June 10, 2010) ─ The number of biotechnology companies operating in New Jersey continues to increase significantly despite the downturn in the economy, ongoing difficulties in obtaining venture capital and other forms of funding and a contraction in the biotechnology and pharmaceutical industries at both the state and national levels, according to initial results from an industry survey released today by BioNJ, the trade association for the biotechnology industry in New Jersey. Read more »

BioNJ Holds New Jersey’s Only BioPartnering Conference on June 14-15 in Princeton

TRENTON, NJ (June 7, 2010) – BioNJ, New Jersey’s trade association for the biotechnology industry, will hold its 2010 BioPartnering Conference on June 14 and 15 at the Westin Princeton at Forrestal Village, in Princeton, NJ. Read more »

Greater Philadelphia Region Life Sciences Cluster Attains Top Rankings

A comparative study conducted by the Milken Institute ranks the Greater Philadelphia region second in the study’s Overall Composite Index, after only Boston and ahead of Greater San Francisco.
Read more »

BioNJ Welcomes New and Returning Members to the Board of Trustees

TRENTON (January 28, 2010) – At its 17th Annual Meeting on January 28, BioNJ’s Board of Trustees announced the appointment of three new board members, and reappointment of five board members. The mission of the Board is to help foster a positive culture for biotechnology companies to prosper in New Jersey. Read more »

BioNJ Presents Third Annual Dr. Sol J. Barer Award for Vision, Leadership to Lilly’s John Johnson

TRENTON, NJ – January 22, 2010 — BioNJ, New Jersey’s trade association for the biotechnology community, announced today that the third annual Dr. Sol J. Barer Award for Vision, Innovation and Leadership has been awarded to John H. Johnson, President of Global Oncology and Senior Vice President of Eli Lilly and Company.  Read more »

Career Expo Draws 500 Professionals Looking for Work in the Biotechnology & Pharmaceutical Industries

NEW BRUNSWICK, June 17, 2011 – More than 500 professionals equipped with resumes and dressed for success showed up to meet employers looking to fill jobs in the state’s growing bio-technology, pharmaceutical and life sciences industries today.

The New Jersey Department of Labor and Workforce Development (LWD) teamed with the BioNJ Talent Network to host the free “Career Expo” held at the Student Center on the campus of Rutgers University in New Brunswick. Read more »

BioNJ Elects New Officers; Adds Five New Members to Board of Trustees

TRENTON (January 23, 2009) — BioNJ, New Jersey’s trade association for bioscience companies, announced today that at its January 22, 2009 Annual Meeting, Dinner and Awards Program the Board of Trustees named new officers and elected five new members. The mission of the Board is to help foster a positive culture for biotechnology companies to prosper in New Jersey. Read more »

BioNJ Presents 2nd Annual Dr. Sol J. Barer Award for Vision, Innovation and Leadership to Genmab CEO, Lisa N. Drakeman, Ph.D.

TRENTON (January 22, 2009) — BioNJ, New Jersey’s trade association for bioscience companies, announced today that the second annual Dr. Sol J. Barer Award for Vision, Innovation and Leadership had been awarded to Lisa N. Drakeman, Ph.D., who is Chief Executive Officer of Genmab of Princeton, NJ. Read more »